Artivion Projects 2026 Revenue Between $484M and $492M Amid NEXUS Product Preparation

Artivion, Inc. (AORT) reported a third-quarter constant currency revenue growth of 9% year-over-year. However, the company experienced an 8% decline in adjusted EBITDA during the same period, according to CEO James Mackin. Looking ahead, the company has provided revenue guidance for 2026, forecasting between $484 million and $492 million. Management is currently focusing on preparations for the January 2027 launch of its NEXUS product line.

By SA Transcript Insights Editor, SA News Editor · Seeking Alpha ·

Artivion Projects 2026 Revenue Between $484M and $492M Amid NEXUS Product Preparation

Tickers: $AORT

Topics: EBITDA decline revenue growth stent graft revenue

Read the full article at Seeking Alpha

More World news